ArticleOncology letters2026

Effect of apalutamide dosage on the incidence of cutaneous adverse events and prostate-specific antigen reduction in patients with prostate cancer.

Takuya Matsuyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.